Cargando…
Trends in Phase II Trials for Cancer Therapies
SIMPLE SUMMARY: Through time we have optimized drug combinations to treat cancer. Today we count with a better arsenal of cancer drugs acting on specific genes, known as targeted cancer therapies. Targeted therapies were promising as single drugs, avoiding the inevitable side effects of drug combina...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825663/ https://www.ncbi.nlm.nih.gov/pubmed/33430223 http://dx.doi.org/10.3390/cancers13020178 |